EARLY TAVR: Delayed TAVR Linked with Increased Risk of Death, Stroke, HF, or HFH Within 2 Years
Key Points: In this sub analysis of the EARLY TAVR trial, the authors aim to evaluate outcomes among all patients who underwent transcatheter aortic valve replacement... Read more.
Early, Short-Term Use of Rivaroxaban Plus DAPT Significantly Reduces Intracoronary Thrombus
Key Points: In the ARISE-ARMYDA 7 trial, 40 patients who presented with ST elevation myocardial infarction and a plan for a deferred stenting strategy were randomized... Read more.
Comparison Of Angiography-Derived FFR to IVUS in PCI: FLAVOUR II
Key Points: In the FLAVOUR II trial, 1839 patients with angiographically-significant coronary artery disease were randomized to receive angiography-derived fractional... Read more.
No Difference with Mobile Integrated Health vs A Transitions Of Care Coordinator in HF: MIGHTy-Heart
Key Points: In the MIGHT-y Heart Trial, 2,003 patients who were hospitalized for heart failure across 11 hospitals in New York City were randomized to receive... Read more.
Electronic Provider Notification Significantly Improved Quality of Care Delivered for Severe AS: DETECT AS
Key Points: In the DETECT AS trial, 285 providers for 939 patients with severe aortic stenosis were randomized to receive an electronic provider notification (EPN)... Read more.
WARRIOR Trial: Intensive Medical Therapy Didn’t Lower Events in INOCA vs Usual Care
Key Points: In the WARRIOR trial, ~ 2500 women with signs and symptoms of ischemia without obstructive coronary disease (INOCA) were randomized to receive intensive... Read more.